Covid 19 Vaccine Storage
- All
- News
- Videos
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
- Saturday April 16, 2022
- India News | Press Trust of India
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
- www.ndtv.com
-
IBM Uncovers More Attacks Against COVID-19 Vaccine Supply Chain
- Thursday April 15, 2021
- Jordan Robertson, Bloomberg
A hacking campaign that IBM detected last year against organisations involved in the manufacturing, transportation, and storage of COVID-19 vaccines was wider than initially understood and is now found to have targeted more than 40 companies in 14 countries, the company said.
- www.gadgets360.com
-
Pfizer Soars 19% To All-Time High After Parent Company's Successful Vaccine Trials
- Tuesday November 10, 2020
- Business | Edited by Peter Noronha
Pfizer said its COVID-19 vaccine, developed in association with the German partner BioNTech SE, was more than 90 per cent effective against SARS-CoV-2.
- www.ndtv.com/business
-
New Indian Covid Vaccine Candidate Can Withstand Even 100 Degrees Celsius
- Saturday April 16, 2022
- India News | Press Trust of India
A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
- www.ndtv.com
-
IBM Uncovers More Attacks Against COVID-19 Vaccine Supply Chain
- Thursday April 15, 2021
- Jordan Robertson, Bloomberg
A hacking campaign that IBM detected last year against organisations involved in the manufacturing, transportation, and storage of COVID-19 vaccines was wider than initially understood and is now found to have targeted more than 40 companies in 14 countries, the company said.
- www.gadgets360.com
-
Pfizer Soars 19% To All-Time High After Parent Company's Successful Vaccine Trials
- Tuesday November 10, 2020
- Business | Edited by Peter Noronha
Pfizer said its COVID-19 vaccine, developed in association with the German partner BioNTech SE, was more than 90 per cent effective against SARS-CoV-2.
- www.ndtv.com/business